Ectopic Cushing's syndrome due to advanced medullary thyroid cancer: a case report

2021 ◽  
Author(s):  
Andrea Corsello ◽  
Vittoria Ramunno ◽  
Rosa Maria Paragliola ◽  
Giovanni Pacini ◽  
Crea Carmela De ◽  
...  
Keyword(s):  
Thyroid Cancer ◽  
Case Report ◽  
Cushing’S Syndrome ◽  
Medullary Thyroid Cancer ◽  
Cushing's Syndrome ◽  
Medullary Thyroid ◽  
Ectopic Cushing’S Syndrome

Ectopic Cushing's syndrome secondary to medullary thyroid carcinoma with apparent signs of hypercortisolism: a case report

2018 ◽  
Author(s):  
M Masum Canat ◽  
Sezin Dogan Cakir ◽  
Duygu Yildiz ◽  
Feyza Yener Ozturk ◽  
Rumeysa Selvinaz Erol ◽  
...  
Keyword(s):  
Case Report ◽  
Thyroid Carcinoma ◽  
Medullary Thyroid Carcinoma ◽  
Cushing’S Syndrome ◽  
Cushing's Syndrome ◽  
Medullary Thyroid ◽  
Ectopic Cushing’S Syndrome

scholarly journals ACTH-secreting medullary thyroid cancer: a case series

2017 ◽  
Vol 2017 ◽  
Author(s):  
Ayanthi A Wijewardene ◽  
Sarah J Glastras ◽  
Diana L Learoyd ◽  
Bruce G Robinson ◽  
Venessa H M Tsang
Keyword(s):  
Thyroid Cancer ◽  
Cushing’S Syndrome ◽  
Medullary Thyroid Cancer ◽  
Kinase Inhibitors ◽  
Neuroendocrine Tumour ◽  
Therapeutic Option ◽  
Rare Complication ◽  
Cushing's Syndrome ◽  
Ectopic Acth ◽  
Medullary Thyroid

Summary Medullary thyroid cancer (MTC) is a rare neuroendocrine tumour that originates from the parafollicular cells of the thyroid gland. The most common presentation of MTC is with a single nodule; however, by the time of diagnosis, most have spread to the surrounding cervical lymph nodes. Cushing’s syndrome is a rare complication of MTC and is due to ectopic adrenocorticotrophic hormone (ACTH) secretion by tumour cells. Cushing’s syndrome presents a challenging diagnostic and management issue in patients with MTC. Tyrosine kinase inhibitors (TKI) previously used for the management of metastatic MTC have become an important therapeutic option for the management of ectopic ACTH in metastatic MTC. The article describes three cases of ectopic ACTH secretion in MTC and addresses the significant diagnostic and management challenges related to Cushing’s syndrome in metastatic MTC. Learning points: Medullary thyroid cancer (MTC) is a rare neuroendocrine tumour. Cushing’s syndrome is a rare complication of MTC that has a significant impact on patients’ morbidity and mortality. Tyrosine kinase inhibitors (TKI) provide an important therapeutic option for the management of ectopic ACTH in metastatic MTC.

Medullary thyroid cancer and pseudocirrhosis: case report and literature review

2012 ◽  
Vol 19 (1) ◽  
Author(s):  
B. L. Harry ◽  
M.L. Smith ◽  
J.R. Burton Jr ◽  
A. Dasari ◽  
S.G. Eckhardt ◽  
...  
Keyword(s):  
Thyroid Cancer ◽  
Case Report ◽  
Literature Review ◽  
Medullary Thyroid Cancer ◽  
Medullary Thyroid

Selpercatinib as an alternative therapy to Lenvatinib for metastatic medullary thyroid cancer. A case report.

2021 ◽  
Author(s):  
Pascual Cristina Contreras ◽  
Mendez Cristina Montalban ◽  
Tirado Antonio Moreno ◽  
Zhao Montero Benítez Maria ◽  
González Lázaro Paloma ◽  
...  
Keyword(s):  
Thyroid Cancer ◽  
Case Report ◽  
Medullary Thyroid Cancer ◽  
Alternative Therapy ◽  
Medullary Thyroid

Ectopic cushing's syndrome secondary to acinic cell carcinoma of the parotida gland: A case-report

2021 ◽  
Author(s):  
Sara Pinheiro ◽  
Juliana Filipe ◽  
Pedro Meireles ◽  
Branco Sara Castelo ◽  
Miguel Rito ◽  
...  
Keyword(s):  
Case Report ◽  
Cell Carcinoma ◽  
Cushing’S Syndrome ◽  
Cushing's Syndrome ◽  
Acinic Cell Carcinoma ◽  
Ectopic Cushing’S Syndrome ◽  
Acinic Cell

Abstract #1003222: Case Report: Medullary Thyroid Cancer as Part of the MEN2B Syndrome in an 8-year-old Male Patient

2021 ◽  
Vol 27 (6) ◽  
pp. S164-S165
Author(s):  
Maria P. Sarmiento ◽  
Judith S. Garcia ◽  
Susana gomez ◽  
Pilar Pereira ◽  
Nora Zuluaga ◽  
...  
Keyword(s):  
Thyroid Cancer ◽  
Case Report ◽  
Male Patient ◽  
Medullary Thyroid Cancer ◽  
Medullary Thyroid
Sign in / Sign up

Export Citation Format

Share Document